J&J Pushed Opioids Like Drug Dealer, Doctor Tells Trial Judge
Law360 (June 12, 2019, 11:35 PM EDT) -- The landmark trial between the state of Oklahoma and Johnson & Johnson took a testy turn Wednesday when a doctor testifying on behalf of the state compared the company's promotional tactics to that of a street-corner drug dealer, prompting the judge to strike the testimony after a heated objection from J&J.
Midway through the third week of the bench trial in Norman, Oklahoma, the state called back to the stand Dr. Andrew Kolodny, the co-director of opioid policy research at Brandeis University and executive director of the organization Physicians for Responsible Opioid Prescribing.
Kolodny was shown internal marketing documents about J&J subsidiary Janssen...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!